Skip to content

Drug interactions

Pexidartinib + Sulindac

Severity: Major

Pexidartinib and Sulindac: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pexidartinib carries a boxed warning for serious and potentially fatal liver injury. Sulindac is among the NSAIDs with a recognized, though uncommon, risk of hepatotoxicity, so combining them may add to liver risk.

What this interaction means in plain words

Pexidartinib and Sulindac can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Pexidartinib belongs to Oncology; Sulindac belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Additive hepatotoxic potential from two drugs that can independently cause liver injury.

What to do

Avoid co-use where possible and choose a non-hepatotoxic analgesic. If used together, monitor liver enzymes and bilirubin closely and stop therapy at signs of liver injury.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pexidartinib and Sulindac, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Pexidartinib with Sulindac?

MediHelp rates the interaction as major. Pexidartinib and Sulindac can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pexidartinib carries a boxed warning for serious and potentially fatal liver injury. Sulindac is among the NSAIDs with a recognized, though uncommon, risk of hepatotoxicity, so combining them may add to liver risk.

How serious is the interaction between Pexidartinib and Sulindac?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid co-use where possible and choose a non-hepatotoxic analgesic. If used together, monitor liver enzymes and bilirubin closely and stop therapy at signs of liver injury.

What other medicines interact with Sulindac?

MediHelp also lists interactions of Sulindac with, for example, Ketorolac intranasal, Ketorolac, Aceclofenac. The full list is on the Sulindac page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in